Published Date: 16 Feb 2023
Using a cell phone as a tactic to distract your child can make behavior problems worse in the future.
Read Full NewsNew phase 3 FREXCITE trial tests frexalimab CD40L inhibitor in nrSPMS, comparing on-body subcutaneous vs IV dosing
Findings from a phase 1 study indicated that Lucid-21-302 was generally well tolerated and exhibited dose-proportional exposure, warranting additional study in a phase 2 trial for multiple sclerosis.
Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D
Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis
1.
Patients value communication skills from cancer surgeons across six key areas, according to research
2.
Surviving cancer, still suffering: Survey reveals gaps in follow‑up care
3.
New tumor therapy approach reduces costs and side effects while increasing accessibility
4.
Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma
5.
New imaging solution could help improve survival for patients with recurring prostate cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Case Study: Revolutionizing PNH Treatment with Eculizumab for Superior Patient Outcomes
3.
Unmasking the Subtle Symptoms of Colon Cancer
4.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
5.
Unveiling the Hidden Mechanisms of Hemolytic Reactions
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VIII
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation